Technology
Novel combination therapy approach to keep leukemia at bay – News-Medical.Net
In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients’ symptoms,…
In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients’ symptoms, but cannot truly change the course of the disease. A study by the University of Basel has shown that it may be possible to…
Continue Reading
-
Noosa News19 hours agoYoung voices shape Sunshine Coast’s future
-
Business19 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoStar Entertainment signs $300m lifeline deal with US gaming giant Bally’s
-
Noosa News18 hours agoQueensland government to review greenhouse gas emission reduction targets